Audax and Linden agree sale of StatLab to Leica Biosystems
PE Hub reported that Leica Biosystems, a Danaher operating company, will buy StatLab Medical Products from Audax Private Equity and Linden Capital Partners.
By Rafael Ortiz · Fintech Correspondent
· 2 min read
Audax Private Equity and Linden Capital Partners have agreed to sell StatLab Medical Products to Leica Biosystems, PE Hub reported. Financial terms were not reported, leaving the valuation and immediate financial effect of the transaction undisclosed.
StatLab is based in McKinney, Texas, and makes pre-analytical products, according to PE Hub. The company’s products are supplied to laboratories and original equipment manufacturer customers in the US and Europe.
Leica Biosystems is an operating company of Danaher Corporation, PE Hub reported. The transaction would transfer StatLab from two private equity owners to a strategic buyer active in the life sciences and diagnostics supply chain.
Private equity exit in healthcare products
The deal represents an exit by Audax and Linden from a healthcare products manufacturer. In a private equity sale, sponsors typically sell their ownership interests to another financial sponsor or to a corporate acquirer. PE Hub reported Leica Biosystems as the buyer in this case.
The report did not provide a purchase price, expected closing date, financing structure or regulatory conditions. Without those details, investors and industry participants have limited information on the scale of the transaction or its impact on Danaher’s reported financials.
StatLab was founded in 1976, according to PE Hub. Sung-Dae Hong serves as the company’s chief executive.
Pre-analytical products are used in the stages of laboratory work that precede analysis, including preparation and handling functions. PE Hub described StatLab as serving both laboratory customers and OEM customers, giving the business exposure to end users as well as companies that incorporate or distribute products under their own systems or brands.
Healthcare manufacturing businesses serving diagnostic and laboratory workflows have remained an active area for private equity and strategic buyers, given recurring demand from clinical, research and industrial customers. PE Hub’s report places StatLab within that field, with a customer base spanning the US and Europe.
Audax Private Equity and Linden Capital Partners are listed by PE Hub as the selling parties. PE Hub did not report whether either firm will retain any stake in StatLab after the sale.
This story draws on original reporting from PE Hub.
